Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PANACEA BIOTECH vs ABBOTT INDIA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PANACEA BIOTECH ABBOTT INDIA PANACEA BIOTECH/
ABBOTT INDIA
 
P/E (TTM) x -60.9 50.0 - View Chart
P/BV x 0.9 18.2 4.8% View Chart
Dividend Yield % 0.0 1.2 -  

Financials

 PANACEA BIOTECH   ABBOTT INDIA
EQUITY SHARE DATA
    PANACEA BIOTECH
Mar-23
ABBOTT INDIA
Mar-23
PANACEA BIOTECH/
ABBOTT INDIA
5-Yr Chart
Click to enlarge
High Rs19122,482 0.9%   
Low Rs10716,156 0.7%   
Sales per share (Unadj.) Rs75.12,517.0 3.0%  
Earnings per share (Unadj.) Rs-5.5446.8 -1.2%  
Cash flow per share (Unadj.) Rs0.9479.7 0.2%  
Dividends per share (Unadj.) Rs0325.00 0.0%  
Avg Dividend yield %01.7 0.0%  
Book value per share (Unadj.) Rs137.71,480.5 9.3%  
Shares outstanding (eoy) m61.2521.25 288.2%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x2.07.7 25.9%   
Avg P/E ratio x-27.143.2 -62.7%  
P/CF ratio (eoy) x170.040.3 422.1%  
Price / Book Value ratio x1.113.0 8.3%  
Dividend payout %072.7 -0.0%   
Avg Mkt Cap Rs m9,142410,513 2.2%   
No. of employees `000NANA-   
Total wages/salary Rs m1,2655,636 22.4%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m4,59953,487 8.6%  
Other income Rs m5171,543 33.5%   
Total revenues Rs m5,11655,030 9.3%   
Gross profit Rs m4712,055 0.4%  
Depreciation Rs m391700 55.9%   
Interest Rs m44160 27.7%   
Profit before tax Rs m12812,738 1.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m4663,244 14.3%   
Profit after tax Rs m-3379,494 -3.6%  
Gross profit margin %1.022.5 4.5%  
Effective tax rate %363.525.5 1,427.4%   
Net profit margin %-7.317.8 -41.3%  
BALANCE SHEET DATA
Current assets Rs m5,62330,251 18.6%   
Current liabilities Rs m3,29712,060 27.3%   
Net working cap to sales %50.634.0 148.7%  
Current ratio x1.72.5 68.0%  
Inventory Days Days5987 67.6%  
Debtors Days Days482 2,204.8%  
Net fixed assets Rs m7,02815,135 46.4%   
Share capital Rs m61213 28.8%   
"Free" reserves Rs m8,37531,248 26.8%   
Net worth Rs m8,43631,460 26.8%   
Long term debt Rs m2020-   
Total assets Rs m12,71245,386 28.0%  
Interest coverage x3.980.7 4.8%   
Debt to equity ratio x00-  
Sales to assets ratio x0.41.2 30.7%   
Return on assets %-2.321.3 -10.8%  
Return on equity %-4.030.2 -13.3%  
Return on capital %2.041.0 4.9%  
Exports to sales %43.30.4 10,473.8%   
Imports to sales %24.410.8 226.7%   
Exports (fob) Rs m1,992221 900.7%   
Imports (cif) Rs m1,1245,765 19.5%   
Fx inflow Rs m1,992310 643.1%   
Fx outflow Rs m1,1915,818 20.5%   
Net fx Rs m801-5,508 -14.5%   
CASH FLOW
From Operations Rs m-4,2258,934 -47.3%  
From Investments Rs m4,303-1,477 -291.3%  
From Financial Activity Rs m-184-6,387 2.9%  
Net Cashflow Rs m-1051,070 -9.8%  

Share Holding

Indian Promoters % 73.6 0.0 -  
Foreign collaborators % 0.0 75.0 -  
Indian inst/Mut Fund % 1.0 8.9 10.7%  
FIIs % 0.3 0.2 144.4%  
ADR/GDR % 0.0 0.0 -  
Free float % 26.4 25.0 105.6%  
Shareholders   47,091 72,252 65.2%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PANACEA BIOTECH With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on Panacea Biotech vs Abbott India

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Panacea Biotech vs Abbott India Share Price Performance

Period Panacea Biotech Abbott India S&P BSE HEALTHCARE
1-Day -1.74% 0.74% 1.18%
1-Month -20.01% -5.97% -0.75%
1-Year 11.75% 24.80% 61.82%
3-Year CAGR -12.26% 21.40% 18.16%
5-Year CAGR -9.98% 29.91% 19.79%

* Compound Annual Growth Rate

Here are more details on the Panacea Biotech share price and the Abbott India share price.

Moving on to shareholding structures...

The promoters of Panacea Biotech hold a 73.6% stake in the company. In case of Abbott India the stake stands at 75.0%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Panacea Biotech and the shareholding pattern of Abbott India.

Finally, a word on dividends...

In the most recent financial year, Panacea Biotech paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of -0.0%.

Abbott India paid Rs 325.0, and its dividend payout ratio stood at 72.7%.

You may visit here to review the dividend history of Panacea Biotech, and the dividend history of Abbott India.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.